Skip to main content
Caplight Logo









Nohla Therapeutics

Nohla Therapeutics

Private
Seattle, WashingtonHealthcare & Life Sciencesnohlatherapeutics.com

Company Overview

Nohla Therapeutics is a biotechnology company that develops off-the-shelf, universal donor cellular therapies for patients with hematologic malignancies and other critical diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cellular therapystem cell therapyoff-the-shelf therapyhematologic malignanciesumbilical cord bloodnotch ligand technologydilanubicelallogeneic transplantcell expansionneutropenia treatmentbiotechcell therapy manufacturingclinical-stage biotechregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nohla Therapeutics Comparables

Compare Nohla Therapeutics with similar companies based on industry and business-model similarity.

Nohla Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ExCellThera
82%
Angiocrine Bioscience
79%
Gamida Cell Ltd.
78%

Nohla Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Nohla Therapeutics Filings

Explore SEC and related filing metadata, where available.

Nohla Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nohla Therapeutics's valuation, stock price, and market status.

Is Nohla Therapeutics a public or private company?

Nohla Therapeutics is a private company.

What is the current stock price of Nohla Therapeutics?

Nohla Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Nohla Therapeutics worth (valuation)?

Valuation information for Nohla Therapeutics is not publicly available.

Can I buy Nohla Therapeutics stock?

Nohla Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nohla Therapeutics's last funding round?

Funding round information for Nohla Therapeutics is not publicly available.

Who are the main investors in Nohla Therapeutics?

Investor information for Nohla Therapeutics is not publicly disclosed.

Will Nohla Therapeutics IPO soon?

No public IPO plans have been announced for Nohla Therapeutics.

How can I track Nohla Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nohla Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2015
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?